Journal Club: Impact of Stress, Anxiety, Depression on Chronic Kidney Disease and its Effects on Quality of Life

Stress, anxiety, and depression moderately impact the QOL for CKD patients, reports a recent article published in the Global Journal of Medical Pharmaceutical and Biomedical Update published by Scientific Scholar.

The original article aimed to evaluate the levels of these three parameters including stress, anxiety, and depression in patients with chronic kidney disease and also to examine their impact on quality of life.

The study was conducted at KIMS-Saveera in Anantapur and focused on 400 individuals diagnosed with CKD. To gather information, an online survey using Google Forms was employed. This survey included questions about health, as well as assessments using the Depression, Anxiety, and Stress Scale-21 to understand mental well-being and the kidney-related QOL scale to evaluate the QOL related to kidney disease.

The survey revealed that 300 males and 100 females participated in the study, and most of the participants had moderate levels of depression (41.3), anxiety (37.5), and stress (31.7). Notably, a significant negative correlation was observed between age and psychological health.

Hence, it was concluded that that stress, anxiety, and depression moderately impact the QOL for CKD patients. The findings underscore the importance of considering mental health factors in the overall care of individuals and emphasizing a holistic approach to address both physical and emotional well-being.

Reference: Roy S, Ishrar SM, Caleerappa R, Reddy VB, Chenna N, Chapiri D. Impact of Stress, Anxiety, and Depression on Chronic Kidney Disease and its Effects on Quality of Life. Glob J Med Pharm Biomed Update. 2024;19:3. doi: 10.25259/GJMPBU_108_2023